Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Bagg

Showing results (161-170 of 217) with videos related to

Pageof 22
Sort By:
Leukemia Research|May 21, 2023
Acute leukemias with complex karyotype show a similarly poor outcome independent of mixed, myeloid or lymphoblastic immunophenotype: A study from the Bone Marrow Pathology GroupTimothy Kirtek, Weina Chen, Dorottya Laczko, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 13, 2018
Myeloproliferative neoplasms with concurrent BCR-ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology groupCraig R Soderquist, Mark D Ewalt, David R Czuchlewski, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 27, 2017
Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemiaJulia T Geyer, Wayne Tam, Yen-Chun Liu, et al.
Leukemia Research|February 12, 2023
Clinicopathologic characteristics of myeloproliferative neoplasms with JAK2 exon 12 mutationKran Suknuntha, Julia T Geyer, Keyur Pravinchandra Patel, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 7, 2018
A reevaluation of erythroid predominance in Acute Myeloid Leukemia using the updated WHO 2016 CriteriaElizabeth Margolskee, Geoff Mikita, Bryan Rea, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 21, 2025
Clinical Impact of Next-Generation Sequencing of T-Cell Lymphomas: A Single Institution ExperienceOmar Elghawy, Julia Wang, Olivia J Leung, et al.
Blood Advances|September 1, 2023
Treatment consistent with idiopathic multicentric Castleman disease guidelines is associated with improved outcomesSheila K Pierson, Megan S Lim, Gordan Srkalovic, et al.
American Journal of Clinical Pathology|November 21, 2020
Laboratory Workup of Lymphoma in AdultsSteven H Kroft, Cordelia E Sever, Adam Bagg, et al.
Archives of Pathology & Laboratory Medicine|November 11, 2020
Laboratory Workup of Lymphoma in Adults: Guideline From the American Society for Clinical Pathology and the College of American PathologistsSteven H Kroft, Cordelia E Sever, Adam Bagg, et al.
American Journal of Clinical Pathology|April 5, 2017
Most Myeloid Neoplasms With Deletion of Chromosome 16q Are Distinct From Acute Myeloid Leukemia With Inv(16)(p13.1q22): A Bone Marrow Pathology Group Multicenter StudyHeesun J Rogers, Eric D Hsi, Guilin Tang, et al.
Pageof 22

Showing results (161-170 of 217) with videos related to

Sort By:
Pageof 22
Leukemia Research|May 21, 2023
Acute leukemias with complex karyotype show a similarly poor outcome independent of mixed, myeloid or lymphoblastic immunophenotype: A study from the Bone Marrow Pathology GroupTimothy Kirtek, Weina Chen, Dorottya Laczko, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 13, 2018
Myeloproliferative neoplasms with concurrent BCR-ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology groupCraig R Soderquist, Mark D Ewalt, David R Czuchlewski, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 27, 2017
Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemiaJulia T Geyer, Wayne Tam, Yen-Chun Liu, et al.
Leukemia Research|February 12, 2023
Clinicopathologic characteristics of myeloproliferative neoplasms with JAK2 exon 12 mutationKran Suknuntha, Julia T Geyer, Keyur Pravinchandra Patel, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 7, 2018
A reevaluation of erythroid predominance in Acute Myeloid Leukemia using the updated WHO 2016 CriteriaElizabeth Margolskee, Geoff Mikita, Bryan Rea, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 21, 2025
Clinical Impact of Next-Generation Sequencing of T-Cell Lymphomas: A Single Institution ExperienceOmar Elghawy, Julia Wang, Olivia J Leung, et al.
Blood Advances|September 1, 2023
Treatment consistent with idiopathic multicentric Castleman disease guidelines is associated with improved outcomesSheila K Pierson, Megan S Lim, Gordan Srkalovic, et al.
American Journal of Clinical Pathology|November 21, 2020
Laboratory Workup of Lymphoma in AdultsSteven H Kroft, Cordelia E Sever, Adam Bagg, et al.
Archives of Pathology & Laboratory Medicine|November 11, 2020
Laboratory Workup of Lymphoma in Adults: Guideline From the American Society for Clinical Pathology and the College of American PathologistsSteven H Kroft, Cordelia E Sever, Adam Bagg, et al.
American Journal of Clinical Pathology|April 5, 2017
Most Myeloid Neoplasms With Deletion of Chromosome 16q Are Distinct From Acute Myeloid Leukemia With Inv(16)(p13.1q22): A Bone Marrow Pathology Group Multicenter StudyHeesun J Rogers, Eric D Hsi, Guilin Tang, et al.
Pageof 22